What Is Ipamorelin?
Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue receptor (GHSR) agonist. It stimulates GH release from the anterior pituitary by mimicking ghrelin at the GHSR receptor. Research interest in Ipamorelin centres on its selectivity profile: studies indicate it stimulates GH release with substantially less effect on cortisol, prolactin, and ACTH compared to earlier GHRP compounds such as GHRP-2 and GHRP-6.
Ipamorelin is frequently studied in combination with CJC-1295, a GHRH analogue that acts on a separate receptor pathway. The two compounds have complementary mechanisms — GHSR agonism (Ipamorelin) and GHRH receptor agonism (CJC-1295) — which has generated research interest in their combined effects on GH pulse frequency and amplitude.
This page covers procurement. For full research background including mechanism of action, receptor pharmacology, and combination study design, see the CJC-1295 and Ipamorelin Researcher's Guide. For research use only.
Ipamorelin Product
Supplied in boxes of 10 research-grade vials.
Why Researchers Choose Eternal Peptides
Janoshik-Verified Every Batch
HPLC purity, mass spectrometry identity, sterility (USP), endotoxin (LAL), and heavy metals (ICP-MS). COAs are published on each product page before you order and the report number can be verified independently at janoshik.com.
Australian-Owned, ABN Registered
Eternal Peptides Wholesale is an ABN-registered Australian business dispatching domestically — not an overseas supplier behind a local domain. ABN shown on all invoices and documentation.
Wholesale Box Pricing
Ipamorelin is supplied in boxes of 10 vials at wholesale pricing. No per-vial retail markups. Structured for research procurement budgets with volume discounts available for multi-box orders.
1-2 Day Dispatch
Orders dispatched within 1-2 business days of payment confirmation. Domestic Australian dispatch. COA documentation included with every order.
Ipamorelin and CJC-1295: Combination Research
The most common research context for Ipamorelin involves its study alongside CJC-1295. The rationale comes from their complementary receptor targets: Ipamorelin acts on the GHSR (growth hormone secretagogue receptor), while CJC-1295 acts on the GHRH receptor. Both stimulate GH release via distinct pathways, making combination protocols a natural area of research interest.
Eternal Peptides Wholesale also stocks CJC-1295 without DAC (10mg) and CJC-1295 without DAC (50mg) for combination research protocols. For detailed mechanistic background and study design considerations, see the CJC-1295 and Ipamorelin Researcher's Guide. For research use only.
Frequently Asked Questions
Where can I buy Ipamorelin in Australia? +
Eternal Peptides Wholesale is an Australian-owned, ABN-registered distributor supplying Ipamorelin for research purposes. IP10 (10mg, box of 10 vials) is $495.00. Janoshik-verified with COAs published on the product page. Dispatched from Australia within 1-2 business days. For research use only.
What makes Ipamorelin different from other GHRPs? +
Ipamorelin is noted for its selectivity. Research indicates it stimulates GH release with less effect on cortisol, prolactin, and ACTH compared to earlier GHRP compounds such as GHRP-2 and GHRP-6. This selectivity profile has made it a common subject of GH secretion research. For research use only.
How is the quality of Ipamorelin verified? +
Every batch is independently tested by Janoshik Analytical. Testing covers HPLC purity, mass spectrometry identity confirmation, sterility (USP method), endotoxin (LAL assay), and heavy metals (ICP-MS). The COA is published on the IP10 product page. The Janoshik report number can be independently verified at janoshik.com before or after purchase. For research use only.
Is Ipamorelin studied with CJC-1295? +
Yes — Ipamorelin is frequently studied in combination with CJC-1295. They act on different receptor pathways (GHSR and GHRH receptor respectively), making their combined effect on GH secretion an active area of research. Eternal Peptides Wholesale stocks both compounds. See the CJC-1295 and Ipamorelin Researcher's Guide for protocol background. For research use only.
Is Ipamorelin approved for human use in Australia? +
No. Ipamorelin is not approved by the TGA for therapeutic use in Australia. Eternal Peptides Wholesale supplies Ipamorelin for qualified laboratory research use only — not for human therapeutic use or consumption. Customers should consult their own legal and compliance advisors regarding applicable obligations.